Humanised Igg1 Monoclonal Antibody Against Cldn6 Conjugated To Monomethyl Auristatin E Via A Cathepsin Hydrolysable Dipeptide Vc Linker

1 trials Orphan designation

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

0 Recruiting

0 Completed trials

1 Sponsors

8 Countries

Phase II

Phase II: 1

Oversight events:

8 temporary halts across 1 trial

Sponsors using this IMP

1 total

CATALINA-2: A Phase 2 Study of TORL-1-23 in Advanced Ovarian Cancer Halted

2024-517190-24-00 Phase II 8 countries Torl Biotherapeutics LLC

Showing 1–1 of 1 trials